In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...